about
Do advanced glycation end-products play a role in malaria susceptibility?Can erythropoietin be used to prevent brain damage in cerebral malaria?Real-time PCR for dihydrofolate reductase gene single-nucleotide polymorphisms in Plasmodium vivax isolates7-Chloro-4-aminoquinoline γ-hydroxy-γ-lactam derived-tetramates as a new family of antimalarial compounds.Identification of the Plasmodium vivax mdr-like gene (pvmdr1) and analysis of single-nucleotide polymorphisms among isolates from different areas of endemicity.An outbreak of locally acquired Plasmodium vivax malaria among migrant workers in Oman.Cellular immune responses to recombinant antigens in pregnant women chronically infected with Toxoplasma gondii.A multicenter, randomized, open-label, controlled study comparing the efficacy, safety and cost-effectiveness of a sequential therapy with RV4104A ointment, ciclopiroxolamine cream and ciclopirox film-forming solution with amorolfine nail lacquer alErythropoietin Combined with Liposomal Amphotericin B Improves Outcome during Disseminated Aspergillosis in MiceGood efficacy of artemether-lumefantrine for uncomplicated falciparum malaria in eastern Sumba, East Nusatenggara, Indonesia.Therapeutic efficacy of artemether-lumefantrine for Plasmodium vivax infections in a prospective study in Guyana.Evaluation of the malaria rapid diagnostic test VIKIA malaria Ag Pf/Pan™ in endemic and non-endemic settingsEfficacy of intranasal administration of artesunate in experimental cerebral malariaDrying anti-malarial drugs in vitro tests to outsource SYBR green assays.Invasive aspergillosis in patients with hematologic malignancies: incidence and description of 127 cases enrolled in a single institution prospective survey from 2004 to 2009.The Other Face of Artesunate: Southern Drug to Treat Northern Diseases.Ex vivo activity of the ACT new components pyronaridine and piperaquine in comparison with conventional ACT drugs against isolates of Plasmodium falciparum.Genetic diversity of Plasmodium vivax metacaspase 1 and Plasmodium vivax multi-drug resistance 1 genes of field isolates from Mauritania, Sudan and Oman.Droplet microfluidics platform for highly sensitive and quantitative detection of malaria-causing Plasmodium parasites based on enzyme activity measurement.Plasmodium vivax dhfr and dhps mutations in isolates from Madagascar and therapeutic response to sulphadoxine-pyrimethamine.Low infectivity of Plasmodium falciparum gametocytes to Anopheles gambiae following treatment with sulfadoxine-pyrimethamine in Mali.Longitudinal study assessing the return of chloroquine susceptibility of Plasmodium falciparum in isolates from travellers returning from West and Central Africa, 2000-2011Tumor necrosis factor production by human macrophages stimulated in vitro by Plasmodium falciparumPlasmodium vivax resistance to chloroquine in Madagascar: clinical efficacy and polymorphisms in pvmdr1 and pvcrt-o genes.Possible role of specific immunoglobulin M antibodies to Plasmodium falciparum antigens in immunoprotection of humans living in a hyperendemic area, Burkina Faso.A systematic review and meta-analysis of evidence for correlation between molecular markers of parasite resistance and treatment outcome in falciparum malaria.Safety of epoietin beta-quinine drug combination in children with cerebral malaria in Mali.Limited value of assays using detection of immunoglobulin G antibodies to the two recombinant dense granule antigens, GRA1 and GRA6 Nt of Toxoplasma gondii, for distinguishing between acute and chronic infections in pregnant women.Update on genetic markers of quinine resistance in Plasmodium falciparum.Plasmodium vivax malaria: a re-emerging threat for temperate climate zones?[Apoptosis and programmed cell death. Host parasite relationship new paradigm][Outsourced real-time PCR diagnosis of cutaneous leishmaniasis in the outbreak region of Constatine, Algeria]Improvement in the Outcome of Invasive Aspergillosis in a Pediatric Hematology Department: A 10-Year Review.Cryptic Plasmodium ovale concurrent with mixed Plasmodium falciparum and Plasmodium malariae infection in two children from Central African Republic.Sleep patterns in villagers and urban African volunteers in a humid tropical climate: Influence of accessibility to electric light?Wanted Plasmodium falciparum, dead or alive.Short report: prevalence and chloroquine sensitivity of Plasmodium malariae in Madagascar.Advantages and limits of real-time PCR assay and PCR-restriction fragment length polymorphism for the identification of cutaneous Leishmania species in Tunisia.Artesunate-erythropoietin combination for murine cerebral malaria treatment.Real-time PCR assay for the identification of cutaneous Leishmania parasite species in Constantine region of Algeria.
P50
Q24471760-ED16AB87-055C-4323-AD0F-C14B93237BA9Q28300824-E3E12772-EADE-462E-8962-3AC1CF356328Q31081389-F2A2C0E4-1770-4FEB-A418-0B604627ADE5Q31134179-6A2DBF4D-A1B2-4C0A-86F6-8AAE6E5F0BACQ33210182-5E6631AC-D2DC-4946-9D93-A0D64F547FB7Q33893028-931EBE10-5491-4395-A855-1BA4D0C44664Q33943411-5CE9C0E7-011B-448B-AEFD-23F2FAF0B942Q34038259-AFE79879-7AE1-4B84-9302-ECB955E568E1Q34336393-B5BBBB20-C458-493B-9228-F29153543355Q34415526-7B6DFE2A-87D3-4DC8-8135-94FAE966AC97Q34452691-54655097-F5D5-46A9-B727-A041871F0E5EQ34762023-E313A8DB-5616-449A-8F8E-1F99E311DA74Q35060339-F86A80AB-63AB-4CBE-BFFB-4005FB1D1512Q35116165-B8130923-366C-4BC6-B853-26002C3328CEQ35528678-3AFA8BEF-D106-4120-8D97-74DA4B15045BQ35797748-CBF8F3D0-7642-4316-B123-B2C299BD3F7FQ35834198-6DED4472-1748-4AE5-8519-B1943B95D591Q36268240-5757BB43-066C-48E7-882F-A0073D3DDA7CQ36484441-B4910246-A6E7-4294-80C1-95F3D4B5802DQ36498859-7BF6BD57-6999-44AC-86A2-98084169C164Q36608075-EF8E2F43-63B5-4D6B-B5EE-416EDC292920Q36643101-199B0B1C-6E80-4C17-ACBE-B55C439D2BE6Q36976057-F1196482-5D69-4ABF-AE3B-44D588C25E13Q36993444-31B8E0EE-23DB-46DE-BB7F-A4971CF238F1Q37066114-9BAB0A20-28F2-4A20-809E-2CD3E0D91C07Q37190605-9BCD59E9-884C-4C27-BE44-6A35C2E4DDF7Q37295436-2AAFDE91-D793-4AEE-B998-E052EA8A5EF0Q37594885-3DCEA40F-0D8D-4196-9940-8DF78336AD81Q37835911-FBC435C3-2BB9-49D7-82FA-A3A803F9BF16Q38090116-BBB36CA1-0D24-4B73-9904-0DB9CC0DE852Q38483837-B5ABC945-4024-4582-B8A9-5BD036D2C248Q38484306-4A0027F6-0BDA-4662-8757-AECB3D8E6CDFQ38545524-A8BC2864-29CE-4107-9920-7BABF52AD2C9Q38642114-FF35CC98-8D11-40C2-8E7C-D2A8D9B1834AQ38826092-F6892AF6-C100-4FAC-802A-0E2990D8EAF2Q38867972-ED338F94-20E1-44A9-93DF-343C9AC613AAQ38893763-F2767965-92B9-4C7E-B740-1F4EE7A60906Q38901633-59C97B03-BFF0-40AE-9D06-2D6AC0A1063FQ38908750-F5D2845E-DA92-4721-A15B-4B717EC3A05DQ38966390-D560D71C-7371-44F1-B716-993A2D9749BE
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Stephane Picot
@ast
Stephane Picot
@en
Stephane Picot
@es
Stephane Picot
@nl
Stephane Picot
@sl
type
label
Stephane Picot
@ast
Stephane Picot
@en
Stephane Picot
@es
Stephane Picot
@nl
Stephane Picot
@sl
altLabel
Stephane Picot
@en
prefLabel
Stephane Picot
@ast
Stephane Picot
@en
Stephane Picot
@es
Stephane Picot
@nl
Stephane Picot
@sl
P1053
F-5973-2014
P106
P21
P31
P3829
P496
0000-0002-5735-6759